zotatifin
effector therapeutics
['eft226', 'zotatifin', 'effector therapeutics', '$eftr']
 $eftr press release effector therapeutics reports positive interim results in zotatifin (eft226) phase 1/2 clinical trial at asco 2022 showing safety and tolerability, and initial signals of clinical activity 6/5/2022 9:00:00 pm 
??

SPAC Press Releases, Ranking Tables, Short Volume

Price targets: https://t.co/fErAk4Voph

Main: @spachero2
SEC Filings: @spacHero_SEC